Friday, December 1, 2017

U.S. Opioids Market to Surpass US$ 18,985.4 Million Threshold by 2024

U.S. Opioids Market, By Drugs (Codeine, Fentanyl, Meperidine, Methadone, Morphine, and Hydrocodone) and Therapeutic Application (Pain Management (Neuropathic Pain, Migraine, Back Pain, Osteoarthritis Pain, Cancer Pain, and Others), Cough Treatment, and Diarrhea Treatment) was valued at US$ 12,627.6 million in 2016 and is expected to exhibit CAGR of 5.2% over the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Increasing incidences of chronic diseases, such as cancer and cardiovascular diseases in developed countries such as U.S., easy accessibility and low cost of opioids pain killers compared to other pain killers such as nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen are the major drivers for growth of the U.S. opioids market. Strict regulatory guidelines for opioids prescription and increasing awareness about harmful effects of the drug are restraining growth of the market.  


In October 2017, Government of the U.S. declared the opioid crisis, as a public health emergency. This declaration is expected to increase the awareness about the drug overuse or abuse and it led the doctors to reduce from over-prescribing the opioids drug. Moreover, Attorney General of more than 35 states sent a letter to the America’s Health Insurance Plans, national association whose members provide coverage for health care and related services, urging its members to reconsider coverage policies that may be fueling the growth of opioid crisis. Due to low cost of opioids compared with other painkillers such as nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen, the insurance company has covered the opioid but not costly one which resulted in limited access to costly painkillers. This is the major concern for all states and letter from Attorney general of the states have been sent to modify this coverage policy so that every painkiller have equal access. 
Due to increased focus on opioids drug, leading pharmacy chains such as CVS has also opted to cooperate the government in managing this crisis. CVS health has announced to reduce opioid prescription and has given detailed guidelines for its use. One among such steps is that their chemist are expected to contact doctors in case of is over prescription of drug.
Browse 11 Market Data Tables and 19 Figures spread through 132 Pages and in-depth TOC on U.S. Opioids Market by Drugs (Codeine, Fentanyl, Meperidine, Methadone, Morphine and Hydrocodone) and Therapeutic Application (Pain Management (Neuropathic Pain, Migraine, Back Pain, Osteoarthritis Pain, Cancer Pain, Others), Cough Treatment and Diarrhea Treatment)
To know the latest trends and insights prevalent in the U.S. Opioids Market, click the link below:
According to the National Center for Health Statistics (NCHS), a division of the Centers for Disease Control and Prevention, (CDC) in 2017, drug overdose killed around 64,070 people in the U.S. in 2016, a rise of 21% over the 52,898 drug overdose deaths was recorded in 2015 and death due to synthetic-opioid fatalities more than doubling in number during the same time increasing from 9,945 in 2015 -2016 to 20,145 in 2016 - 2017.
The same source estimated that opioid overdose resulted in the deaths of approximately 300,000 people in the U.S. during 1999 – 2015. The CDC figure also shows that the rate of increase in deaths from synthetic opioid was much higher than natural or semi-synthetic opioids during 1999 - 2015. According to the CDC report, 2016 nearly half of all opioid overdose deaths involved a prescription opioid.
Key Takeaways of the U.S. Opioids Market:
  • The U.S. Opioids market is expected to exhibit a CAGR of 5.2% over the forecast period (2017 – 2025), owing to the increasing incidences of chronic pain, especially in emerging economies.
  • Opioids overuse or abuse, which is contributing significantly to this market expansion has become the major concern in the economy.
  • Alternative drugs like cannabis has gained attraction in recent times for pain management. If proven effective and safe, cannabis has potential to replace the opioids.
  • The use of medical cannabis has been endorsed by numerous professional organizations in the U.S. including the American Academy of Family Physicians (AAFP), the American Public Health Association (APHA), and the American Nurses Association (ANA).
  • Pressure is mounting on leading pharmacy chain, such as CVS to act positively to limit the opioid drug prescription.
  • Key companies covered in the global U.S. opioids market report include Purdue Pharma L.P., Titan Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, Janssen Pharmaceuticals, Inc., Sanofi S.A., Sun Pharmaceuticals Industries Limited, Mallinckrodt Pharmaceuticals, Egalet Corporation, Endo Pharmaceuticals plc, Allergan, Plc., and Pfizer Inc.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Posted by at No comments:

Bone Replacement Products Market to Surpass US$ 46.6 Billion Threshold by 2025

The Global Bone Replacement Products Market, by Product Type (Hip Replacement, Knee Replacement, Trauma and Extremities, and Spine Replacement), by Material (Metals, Ceramics, Plastics, and Combination of Materials), by End User (Hospitals, Orthopedic Clinics, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 31.7 billion in 2016 and is projected to exhibit a CAGR of 4.4% over the forecast period (2017 – 2025), as highlighted in a new report published by Coherent Market Insights. The development of patient-specific hip implants considering the anatomic individuality or extremely difficult reconstructive cases of patients is a major factor propelling the demand for hip replacement products. For instance, Zimmer Biomet’s patient-matched implant (PMI) department works directly with surgeons to address the most severe cases of bone loss or deformity.


Growing preference for minimally invasive procedures to propel growth of market
Minimally invasive and small incision replacement surgery is an evolving area with improved rehabilitation and pain management to accelerate post-surgery recovery. Increasing adoption of minimally invasive techniques by professionals, owing to long-term benefits is expected to propel growth of the bone replacement products market. Moreover, benefits of minimally invasive replacement procedure have been reported to include less damage to soft tissues, leading to a quick and less painful recovery.
Rising number of bone tumors and trauma cases is expected to accelerate the demand for bone replacement products
Treatment of bone cancers with surgical procedures involves replacement of cancerous bone by bone replacement products or implants. Thus, increasing incidence of bone cancers such as osteosarcoma, chondrosarcoma, and Ewing’s sarcoma, which require bone replacement, is in turn expected to propel growth of the bone replacement products market. According to the American Society of Clinical Oncology, 2014, bone sarcomas account for 0.2% of all malignancies globally with the incidence rate for bone and joint malignancies to be 0.9 per 100,000 people annually, in the U.S. Furthermore, increasing cases of bone fracture trauma due to fall, motor vehicle accident or sports, require medical intervention (orthopedics) thus, augmenting the demand for bone replacement products. According to the National Trauma Institute, in 2014, traumatic injury is the major cause of death globally with the major share of road injury (29.1%) and falls (11.6%).
Browse 45 Market Data Tables and 40 Figures spread through 230 Pages and in-depth TOC on “Bone Replacement Products Market”- Global Forecast to 2025
To know the latest trends and insights prevalent in the bone replacement products market, click the link below:
The market players are engaged in strategic acquisitions and collaborations to increase the portfolio diversification and to introduce exciting new platform technologies. For instance, in 2015, United Orthopedic Corporation collaborated with Shinva Medical Instrument Co., Ltd and New China Life Health Co., Ltd. to expand the sales of bone replacement products in China. Furthermore, in 2016, Zimmer acquired LDR Holding Corporation to enhance innovation and growth of their spine segment. The production of innovative products with research and development activities is expected to enhance the competitive environment among the manufacturers. For instance, in 2015, B. Braun Melsungen AG launched a new 7-layer advanced surface technology with zirconium nitride coated on knee implant to improve its mechanical properties and biocompatibility, thus reducing wear rate by 65%.
Key Takeaways of the Bone Replacement Products Market:
  • The global bone replacement products market is expected to exhibit a CAGR of 4.4% over the forecast period, owing to the presence of high potential market especially in Asia Pacific, Latin America, the Middle East, and Africa
  • Among materials, the combination of materials segment holds a dominant position in the market, as these material implants have enhanced wear resistant and biocompatible properties as compared to the other materials
  • Among end user, the ambulatory surgical centers segment is expected to hold a dominant position in the bone replacement products market, owing to the minimal requirement of prolonged postoperative monitoring and hospital stay
Some of the major players operating in the global bone replacement products market are Zimmer Biomet Holdings, Inc., B. Braun Melsungen AG, Stryker Corporation, Smith & Nephew Plc, United Orthopedic Corporation, Depuy Synthes, Medtronic Plc., Japan Medical Dynamic Marketing, Inc., JRI Orthopedics, Exactech, Inc., and Mathys.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Posted by at No comments:

Bone Graft and Substitutes Market to surpass well beyond US$ 4,235.7 Mn by 2025

The Global Bone Graft and Substitutes Market, by Product Type (Bone Grafts and Bone Graft Substitutes), by Application (Spinal Fusion, Dental Bone Grafts, Craniomaxillofacial, Joint Reconstruction, Trauma and Extremities), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 2,640.1 Mn in 2016 and is projected to exhibit a CAGR of 5.5% over the forecast period (2017 – 2025), as highlighted in a new report published by Coherent Market Insights. Rise in number of reconstructive joint surgeries coupled with development of novel bone grafting substitutes are major factors expected to drive growth of the global bone graft and substitutes market over the forecast period.


Number of hip and knee reconstructive joint surgeries are increasing globally due to growing aging population as well as increasing adoption of sedentary lifestyle. According to Canadian Institute of Health Information, the number of knee replacement surgeries increased by 20.3% in Canada from 2009-2010 to 2014-2015. Bone grafts and substitutes are used in order to fill the voids and damages caused in the knees and hips, thereby healing the broken sites through natural growth. These techniques use various advanced machines and equipment for precision, accuracy, and ease. This has led to increase in the success rate of bone graft surgeries, in turn, propelling growth of the market.
Additionally, rise in medical tourism, especially in the developing economies such as Brazil, Belgium, India, China, Hong Kong are also responsible for driving growth of the global bone grafts and substitutes market. Bone grafting procedures performed in these countries are cost-effective, which in turn, drives traction from the populace living in the developed countries where the prices for these procedures are relatively more expensive. Besides cost-savings, surgeries performed in medical tourism countries offer equivalent levels of quality as well as luxurious post-operative care. This helps boost the market for bone graft and substitutes, specifically in  Latin America and Asia Pacific.
Browse 35 Market Data Tables and 30 Figures spread through 287 Pages and in-depth TOC on “Bone Graft and Substitutes Market”- Global Forecast to 2025
To know the latest trends and insights prevalent in the bone graft and substitutes market, click the link below:
Manufacturers are focusing on developing a variety of synthetic bone graft substitutes and derivatives of allografts such as demineralized bone matrix for better results, high performance, and easy accessibility of synthetic compounds. Synthetic enhanced grafts that help in the improvement of the quality of post-surgical recovery are attracting large customer base, majorly owing to the cost effectiveness and reliability offered by these grafts. For instance, i-Factor by Cerapedics is a peptide enhanced graft that is used in cervical discectomy and fusion surgeries. The graft helps to support bone growth through cell attachment and aviation. Moreover, IBI S.A. developed a bone graft named SmartBone through advanced tissue engineering technologies with resorbable polymers and cell nutrients to enable quick and efficient osteoconduction with a well-blended integration.
Key Takeaways of the Bone Graft and Substitutes Market:
  • The global bone graft and substitutes market is expected to exhibit a CAGR of 5% over the forecast period, owing to the presence of potential market especially in Asia Pacific, and Latin America.
  • Among bone grafts, the autografts segment holds a dominant position in the market, as it is the most established procedure in the grafting sector, followed by allografts. The segment is gaining traction due to high availability and ability to suffice almost all the requirements of an ideal bone graft.
  • Among applications, the spinal fusion segment holds a dominant position in the market, owing to significant rise in the number of spinal procedures carried out across the globe
  • Some major players operating in the global bone graft and substitutes market are Ace Surgical Supply Co., Inc., NovaBone Product LLC, Medtronic Plc, Stryker Corporation, Zimmer Biomet Holdings, Inc., BioHorizons Implant Systems, Inc., Novadip Biosciences, Orthofix International N.V., Globus Medical, Inc., and Bone Therapeutics SA.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Posted by at No comments:

Pharmacogenomics Market to Surge Past US$ 14.6 Billion by 2025

The Global Pharmacogenomics Market, by Technology Type (Polymerase Chain Reaction, Sequencing, Microarray, and Other Technologies), and by Application (Drug Discovery and Therapeutic Application) was valued at US$ 7,623.9 million in 2016 and is projected to expand at a CAGR of 7.6% during the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Advancements in technology, increasing developments by key players, rising prevalence of lifestyle related diseases are expected to contribute to meteoric growth of the pharmacogenomics market over the forecast period.


Increasing engagement of pharmaceutical companies in pharmacogenomics is increasing potential opportunities for various phases of drug discovery and development processes. In parallel with rapid advancements in the identification and mapping of Single Nucleotide Polymorphism (SNPs) across the human genome, technological discoveries and enhancements to high-throughput genotyping have also made significant strides. Leading biotech firms have driven genotyping throughput to scales and significantly driving down costs. Pharmacogenomics initiatives have led to new discoveries and development of several treatments that are tailored for specific characteristics such as genetic makeup or genetic profile of an individual tumor, that helps transform the treatment methods. Increasing government funding to help companies develop bioinformatics technology for precision medicine research applications. For instance, in 2017, Armonica Technologies, Inc., an Albuquerque-based company received US$1.5 million from the government’s US $40 million catalyst fund. This fund is intended for seed early-stage companies in New Mexico that are involved in developing novel technologies.
In therapeutic application, oncology portfolio is of strategic importance for researchers to develop more targeted approaches for the treatment of cancer. For an instance, AstraZeneca oncology portfolio will increasingly rely on the use of genetics and genomics for patient identification and stratification, which in turn, provides a source of novel biomarkers and diagnostics. This allows them to streamline the R&D process and help to better understand the biological basis of the diseases that are aiming to be treated. Thus, integration of pharmacogenomics analysis results in increased designing of tailored drugs, which is expected to increase profits for drug manufacturers.
Browse 29 Market Data Tables and 33 Figures spread through 210 Pages and in-depth TOC on " Pharmacogenomics Market, by Technology Type (Polymerase Chain Reaction, Sequencing, Microarray, and Other Technologies), and by Application (Drug Discovery and Therapeutic Application), and by Region - Global Forecast to 2025"
To know the latest trends and insights related to pharmacogenomics market, click the link below:
Asia Pacific is expected to witness highest growth in the global pharmacogenomics market, owing to rising biotechnology and life sciences sector in this region as well as the increasing focus on research and development by the top market players in these regions. For instance, Thermo Fisher Scientific, in 2017, announced an Asia Precision Medicine research array for regional screening initiatives, which has reduced costs and complexity of analysis associated with whole genome sequencing to help the research of diseases among people living in Asia, which in turn, is expected to favor growth of the market in Asia Pacific.
The healthcare facilities and services in the Middle Eastern countries are underdeveloped, however, have high potential to grow in the near future. To accomplish the goal, the Middle Eastern countries are forming alliances with global leading companies as well as government organizations to foster the development of healthcare in these countries. For instance, in 2016, Middle East Medical Assembly at American University of Beirut (AUB) explored precision medicine sector, which is expected to revolutionize the healthcare and disease treatment in the Middle East, as MEMA brings physicians and experts together to discuss the latest challenges and novelties in precision medicine and genomics.
Vendors are continuously investing in the development of the pharmacogenomics for various applications in clinical and translational research to find a solution to the problems of under-served patients, misdiagnoses, adverse drug reactions (ADRs), and ineffective therapeutics, which is projected to provide lucrative growth over the forecast period. In May 2015, Rosetta Genomics Ltd. launched OncoGxOne, Admera Health’s next-generation sequencing (NGS) panel that detects a vast number of genetic alterations implicated in cancer, to provide clear, concise, and actionable clinical recommendations from a single, comprehensive test.
Key Takeaways of the Pharmacogenomics Market:
  • The global pharmacogenomics market is expected to expand at a CAGR of 6% during the forecast period (2017–2025), due to foster collaborations among the pharmaceutical industry, academic researchers, regulators and government organizations across various regions
  • Increasing demand for sequencing, owing to its wide application in cancer pharmacogenetic and ability to sequence large number of genes up to the complete genome in a single reaction.
  • Polymerase Chain Reaction is also expected to show a meteoric growth over the forecast period, as this system provides flexibility in content, high sample throughput, quick sample-to-results turnaround time, and low cost
  • Among applications, drug discovery is the major segment that drives growth, as this is an emerging field and there are currently a large number of pharmacogenomics tests to detect mutations in the genes responsible for various infectious and non-infectious diseases
Some of the major players involved in global pharmacogenomics market are Thermo Fisher Scientific Inc., Bayer AG, AstraZeneca plc, Assurex Health, GE Healthcare, Bristol-Myers Squibb Company, Qiagen, Inc., F. Hoffmann-La Roche Ltd, Transgenomic, Inc., Abbott Laboratories, Inc., and GlaxoSmithKline
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Posted by at No comments:

Middle East Tapentadol Market to Surpass US$ 1.46 Million Threshold by 2025

The Middle East Tapentadol market, by Therapeutic Application (Pain Management (Neuropathic Pain, Cancer Pain, and Others), and Cough Treatment), and by Countries (KSA, UAE, Bahrain, Oman, Qatar, Israel, Iran) was valued at US$ 0.86 million in 2016 and is projected to exhibit a CAGR of 6.1% over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Rising prevalence of pain-associated diseases such as cancer and diabetic neuropathy and unavailability of effective alternate therapy for management of neuropathic pain are expected to be the major factors driving growth of the Middle East tapentadol market over the forecast period.


Janssen Pharmaceutical sold its license of marketing and distribution of the U.S. to Depomed, Inc. and in April 2017, Depomed, Inc. won the patent for tapentadol. Three ongoing clinical trials for tapentadol are being carried on for various indications and age groups. Positive results from these trials is expected to cause the tapentadol market to gain rapid traction. Currently, tapentadol is only approved for consumption by adults and is not recommended for children due to its high therapeutic efficacy. However, one in three clinical trials are subjected to pediatric use.  Grünenthal GmbH is carrying out an open-label trial, enrolling subjects aged 6 years to 18 years, which is estimated to be completed in December 2018. Another trial by St. Olavs Hospital is for pre- and post-operative pain relief after primary knee arthroplasty with estimated study completion year 2021.
Browse 10 Market Data Tables And 11 Figures Spread Through 106 Pages and In-depth TOC on Middle East Tapentadol Market, By Therapeutic Application (Pain Management (Neuropathic Pain, Cancer Pain, And Others), And Cough Treatment), and By Countries (KSA, UAE, Bahrain, Oman, Qatar, Israel, Iran) - Forecast To 2025
To know the latest trends and insights prevalent in the Middle East tapentadol market, click the link below:
Tapentadol can be used for various other applications, as it is also found to be the safest and best first-line treatment choice for advanced chronic kidney disease. However, clinical trials are still required for it to be prescribed for the same. Furthermore, pilot studies have been performed on patients suffering from moderate-to-severe chronic back pain, published in the National Center for Biotechnology Information.
Increasing off-label applications for this moderately addictive drug along with low competition for existing indications, and robust pipeline is expected to boost growth of the tapentadol market over the forecast period.
Key Takeaways of the Middle East Tapentadol Market:
  • The Middle East tapentadol market is expected to exhibit a CAGR of 1% over the forecast period (2017–2025), owing to the high prevalence of pain-related diseases in countries such as Iran, Palestine, and Kingdom of Saudi Arabia. For instance, according to Journal of Taibah University Medical Sciences, the prevalence of diabetic neuropathic pain in Iran was 51.90% in 2016.
  • Positive results of clinical trials of tapentadol are expected to drive growth of the tapentadol market further
  • Absence of generic drugs after patent win by Depomed, Inc. in 2016, has abolished the competition
  • Less likelihood of tough competition from any other opioid for neuropathic pain and absence of any other opioid therapy under research is expected to support growth of the market
  • Some major players operating in the tapentadol market are Depomed, Inc., Janssen Pharmaceutical, Inc., Grünenthal, and Allergan, Plc
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Posted by at No comments:

Lab-On-A-Chip Market to Surpass US$ 10.25 Billion Threshold by 2025

The global lab-on-a-chip market, by Application (Genomics, Proteomics, Diagnostics, and Drug Discovery), by Product Type (Reagents & Consumables, Software, and Instrument), by Technology (Microarrays and Microfluidics), by End User (Hospital, Diagnostic Labs, Academic and Research Institutes, Biotechnology, and Pharmaceutical Companies), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 4.09 Bn in 2016 and is projected to exhibit a CAGR of 10.8 % over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Increasing demand for diagnostic test and advancement in technology of lab-on-a-chip device, with wide number of applications, in turn is projected to fuel growth of the lab-on-a-chip market over the forecast period.
Early detection of diseases help with effective treatment measures. However, diseases such as cancer are difficult to detect, as the symptoms are usually more detectable later stages. Scientists are facing challenges in capturing and analyzing the bioparticles of cancers, as they are very small in size, which fuels demand for lab-on-a-chip in cancer diagnosis. Increasing demand for lab-on-a-chip devices is mainly due to advancements in technology, portability, and re-configurability and applications. Some of the application of lab-on-a-chip devices are flow cytometer lab-on-a-chip for (HIV), immunoassay LoC for bacteria detection, real-time PCR detection chips, DNA chip, gene chip, and cellular analysis chip.


Furthermore, manufacturers are focusing on innovation to tap into emerging markets. For instance, in 2017, scientists of IBM Research are developing lab-on-a-chip nanotechnology that can separate and isolate bioparticles, which are around 20 nanometers in diameter. This in turn, gives access to identify DNA viruses and exosomes. This shows potential of lab-on-a-chip to analyze and reveal the presence of the diseases, even before a person shows the symptoms. Furthermore, in August 2017, Utah’s Brigham Young University used 3D printing technology and microfluidics collectively to develop the smallest viable 3D printed microfluidic device, which can be effective below 100 micrometers, indicating a major innovation in the lab-on-a-chip market.
Browse 30 Market Data Tables and 28 Figures spread through 160 Pages and in-depth TOC on Lab-On-A-Chip Market, by Application (Genomics, Proteomics, Diagnostics, and Drug Discovery), by Product Types (Reagents & Consumables, Software, and Instrument), by Technology (Microarrays and Microfluidics), by End User (Hospital, Diagnostic Labs, Academic and Research Institutes, Biotechnology, and Pharmaceutical Companies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2025
To know the latest trends and insights prevalent in the Lab-on-a-chip market, click the link below:
Major players in the healthcare sector are adopting novel technologies to deliver better care. In October 2017, Micronit, Axxicon and Helvoet collaborated to offer a leading development and manufacturing package to support the growing demand for high volume polymer microfluidic products. This is majorly due to rapid development of diagnostic systems by the health care industry. For instance, Micronit provides innovative lab-on-a-chip and MEMS solutions using micro and nanotechnologies.
Furthermore, lab-on-a-chip use smartphones to quickly detect multiple pathogens. In October 2017, the University of Illinois at Urbana-Champaign and University of Washington at Tacoma has developed a novel platform to diagnose infectious diseases at the point-of-care, using a smartphone as the detection instrument.
Key takeaways of the market:
  • The global lab-on-a-chip market is expected to exhibit a CAGR of 8% over the forecast period (2017–2025), owing to rise in chronic diseases.
  • Asia Pacific is expected to exhibit a highest growth rate, in terms of revenue, in the global lob-on-a-chip market over the forecast period. This is due to increase in prevalence of chronic diseases such as tuberculosis, which in turn fuels growth of the market in the region. The World Health Organization (WHO) estimated that of the 9 million people who developed TB in 2013, 56% were in the South-East Asia and Western Pacific Regions.
  • Among product types, instrument segment accounted for 50.42% share of the lab-on-a-chip market in 2016
Some major players operating in the global lab-on-chip market are Takara Bio Inc., Nobel Biocare Services AG, Bio-Rad Laboratories Inc., PerkinElmer Inc., and Cepheid Inc.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Posted by at No comments:

Cloud Backup Market to Generate a Revenue of US$ 6367 Million by 2025

According to the new market research report "Cloud Backup Market by Component (Solution and Services), by solution (Personal Backup, Business Backup and Cloud backup for Service providers), by services (Management and Customization, Professional Services, Training & consulting and Integration) by Deployment model (Public, Private and Hybrid Cloud), by Organization Size (Small and Medium Enterprises and Large Enterprises), by Verticals (Banking, Financial Services, and Insurance, Consumer Goods and Retail, Education, Government and Public Sector, Healthcare and Life Sciences, Manufacturing, Media and Entertainment, Telecommunication & Ites and Others),  and Geography-Global Forecast to 2025" is projected to generate the revenue of US$1287 million in 2017 and is expected  to reach  US$ 6367 million by 2025.


Cloud backup, or online backup is a service type which is used to back up the data to a remote location. Similar to cloud storage, the cloud backup also contains a features of access and storing data from various locations and connected resources. The increasing data generation, rising adoption of software as a service are some of the key factors fueling growth of the cloud backup market globally.  According to Coherent Market Insights’ study, in 2015, around 65% of the cloud work load was on SaaS and is projected to reach to around 74% by 2020.  Moreover the, increasing IOT devices, rising demand of structure and unstructured data are some of the other factors which drives the cloud backup market globally. 
Browse 40 Market Data Tables and 60 Figures spread through 300 Pages and in-depth TOC on " Cloud Backup Market, by Component (Solution and Services), by Solution (Personal Backup, Business Backup, and Cloud Backup for Service Providers), by Services (Management and Customization, Professional Services, Training & Consulting, and Integration), by Deployment Model (Public, Private, and Hybrid Cloud), by Organization Size (Small and Medium Enterprises and Large Enterprises), and by Verticals (Banking, Financial Services, and Insurance, Consumer Goods and Retail, Education, Government and Public Sector, Healthcare and Life Sciences, Manufacturing, Media and Entertainment, Telecommunication & Ites, and Others) – Global Forecast to 2025"         
To know the latest trends and insights prevalent in the Cloud Backup Market, click the link below
Key Takeaways of the Cloud Backup Market:
  • Global cloud backup market is projected to grow with a CAGR of 22.1% in the forecast period.
  • Among deployment models, the public cloud segment held the dominant position in the cloud backup market in 2016. Increasing workload on public cloud is a major factor for the growth of the segment in the market. According to Coherent Market Insights, in 2016 the public cloud market generated the revenue of US$ 209.2 billion.
  • Among components, the solution segment held a dominant position in the market in 2016. Increasing demand for managing large volume of data sets and increasing adoption of cloud technology has fueled demand for cloud backup solutions.
  • Among services, the training & consulting service segment held a dominant position in the market in 2016. Companies are focusing on providing various educational services through online channels such as blogs, videos, and slide share, which requires cloud storage.
  • The integration service segment is projected to exhibit the highest CAGR over the forecast period. The increasing various cloud service such as software as a service, platform as a service and infrastructure as a service are some of the key factors which boosted the demand of integration services in cloud.
  • North America held a dominant position in the global cloud backup market in 2016. The highly adoption of cloud technology by North America region countries such as The U.S. and Canada have accelerated the market in this region. According to coherent market insights, in 2014 the North America enterprise used over 1,245 cloud applications.
  • Asia Pacific is projected to exhibit the highest CAGR over the forecast period. Rising adoption of digitization by small and medium enterprises fuels the market growth in the region.
  • Some of the major players in the global cloud backup market are Amazon Web Services, Barracuda Networks, Inc., Code42 Software, Inc., Datto, Inc., Dropbox, Inc., Druva Software, EMC Corporation, Google Inc., IBM Corporation, Microsoft Corporation, Oracle Corporation, Veeam Software, and VMware Inc.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Posted by at No comments:

Global Cocoa Market to Surpass US$ 13,739.3 Million by 2025

Global cocoa market was valued at US$ 9,890.6 million in 2016, according to Global Cocoa Market Report, by Source Type (Conventional and Organic), by Application (Bakery Items, Beverages, Confectionary, Cosmetics, Functional Food, and Pharmaceutical), by Process (Dutch and Natural), and by Product Type (Cocoa Butter, Cocoa Liquor, and Cocoa Powder) published by Coherent Market Insights. The cocoa market is expected to register a CAGR of 3.76% over the forecast period (2017-2025), reaching US$ 13,739.3 million by 2025.
Major factors propelling growth of the market include growing demand for fine flavor and high quality cocoa worldwide. Moreover, rising concerns regarding health and wellness among consumers is fueling growth of the cocoa market, as it contains flavonoids. Heath benefits associated with consumption of flavonoids are improved cholesterol level and blood vessel functioning, coupled with reduced blood pressure. Higher health benefits associated with dark chocolate, owing to its higher cocoa content is fuelling the demand for well processed cocoa beans from a fine flavor variety such as trinitario. Dark chocolate accounted for US$ 19.26 billion in 2016 and is expected to show the fastest growth at a CAGR of 8.3% during the forecast period (2017-2025).  Furthermore, the introduction of variety of ingredients such as dry fruits and sea salt is propelling the demand for chocolate worldwide. Barry Callebaut, world’s leading manufacturer of high quality cocoa and chocolate, generated annual sales of approximately US$ 6.9 billion in the fiscal year. The steadily growing chocolate industry supports the overall growth of the cocoa market.  
To know the latest trends and insights prevalent in this market, click the link below:
Browse 90 market data tables* and 60 figures* on "Cocoa Market” - Global forecast to 2025. 
Key Trends and Analysis of the Global Cocoa Market:
  • Among applications, the confectionary segment held a dominant position in the global cocoa market in 2016 and is expected to retain its dominance over the forecast period. In 2015, Switzerland accounted for the highest chocolate confectionary consumption per person in the world. According to Coherent Market Insights, in 2015, the per capita consumption of chocolate confectionery in Switzerland amounted to approximately 9 kilograms whereas in China, the chocolate consumption was 220 grams during the same year. Additionally, Switzerland also houses some of the leading chocolate companies such as Lindt & Sprungli and Nestlé.
  • Among product types, cocoa liquor accounted for the major share in the global coco market in 2016, owing to its increasing use of cocoa liquor in the production of dark chocolate and milk chocolate. Moreover, it is used in other applications such as desserts, drinks, bakery products, ice cream, and ice cream coatings.
Key Takeaways of the Market:
  • Europe held a dominant position in the global cocoa market in 2016, with US$ 4,531.3 million. The region is projected to witness a CAGR of 3.80%, in terms of revenue, during the forecast period from 2017-2025. This is majorly owing to the growing demand for fine flavor cocoa and increasing number of chocolate manufacturers and processing companies in the region. Furthermore, the leading chocolate companies include Ferrero Group, Mars Inc., and Mondelez International Inc., are focusing in premium lines to make specialty chocolate affordable to all class of consumers. Most of the brands offer their products at low prices and in small packets to increase their penetration in price sensitive market as. For instance, Ferrero started its premium lines by offering Rocher in India in 2007. This in turn, is expected to fuel demand for the fine flavor and high quality cocoa and support the overall growth of cocoa market. According to the Center for the Promotion of Imports (CBI), Ministry of Foreign Affairs, in 2017, Europe accounted for approximately 45% of the dark chocolate market and is expected to grow at the global level with an annual rate of 8% by 2019.
  • Europe imports cocoa majorly from West Africa, Latin America, and Caribbean countries. The main suppliers of cocoa from West Africa include Ivory Coast, Ghana, Cameroon, and Nigeria, however, Peru, Colombia, and Nicaragua are accounted as the major importers from Latin America. According to CBI, Ivory Coast recorded an annual growth of 1.4% in cocoa exports to European Union between 2010 and 2014, however, Peru recorded an annual growth of around 46% between 2010 and 2014. Although, the market share of Latin America and Caribbean countries is smaller as compared to West African countries, however the percentage growth of import value is significantly higher.
Major players operating in the global cocoa market include Archer Daniels Midland, Blommer Chocolate Company, Barry Callebaut, Cargill Inc., Cocoa Processing Company, Mars Incorporated, Carlyle Cocoa, The Hershey Company, Puratos Group, Lindt & Sprungli, and United Cocoa Processor Inc.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Posted by at No comments:

Respiratory Inhalers Market to Surge Past US$ 44.8 Billion by 2025

The Global Respiratory Inhalers Market, by Product Type (Dry Powder Inhalers (Single Unit Dose, Multi Dose and Multi Unit Dose), Metered Dose Inhalers and Nebulizers (Compressed, Mesh and Ultrasonic Inhalers), by Application (Asthma, Chronic Obstructive Pulmonary Disease, Pulmonary Arterial Hypertension and Cystic Fibrosis), by Technology (Digital and Manual), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 27,424.4 million in 2016 and is projected to exhibit a CAGR of 5.7% over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights.
Chronic obstructive pulmonary disease (COPD) is a life-threatening disease affecting the lungs characterized by acute breathlessness. In 2015, it was estimated that around 3 million deaths occurred due to sever Chronic Obstructive Pulmonary Disease (COPD), with 90% fatalities reported in low and middle income countries. The two most common forms of COPD include Chronic Bronchitis and Emphysema. According to American Lung Association (ALA), in 2011, over 24 million people in the U.S. suffered from COPD, including 10 million Chronic Bronchitis and over 4.7 million Emphysema cases. The major reason for chronic obstructive pulmonary disease is exposure to tobacco smoke through active or passive smoking. Most chronic obstructive pulmonary disease cases are preventable by avoiding tobacco smoking. However, countries need to adopt the WHO Framework Convention on Tobacco Control (WHO-FCTC) and follow the MPOWER package of measures so that non-smoking becomes the norm globally.
Asthma is also one of the prime conditions leading to respiratory, disease which is characterized by recurring attacks of panting and wheezing. The severity and frequency of asthma varies according to individual. According to Center for Disease Control and Prevention (CDC), in 2015, 25 million people (1 in 13) in the U.S. were suffering from asthma. Under 18 age group, 6.2 million people suffered from asthma. Each year asthma accounts for 14.2 million physician office visits, and 1.8 million emergency visits.
Browse 32 Market Data Tables and 25 Figures spread through 195 Pages and in-depth TOC on Respiratory Inhalers Market by Product Type (Dry Powder Inhalers (Single Unit Dose, Multi Dose and Multi Unit Dose), Metered Dose Inhalers and Nebulizers (Compressed, Mesh and Ultrasonic Inhalers), by Application (Asthma, Chronic Obstructive Pulmonary Disease, Pulmonary Arterial Hypertension and Cystic Fibrosis), by Technology (Digital and Manual), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2025
To know the latest trends and insights prevalent in the Respiratory Inhalers Market, click the link below:
According to Canadian Lung Association (CLA), in 2014, 2.5 million people in Canada suffered from asthma, including 1 million males and 1.4 million females. The number of people having asthma was 0.9 million in Ontario, 0.6 million in Quebec, 0.3 million in British Colombia, and Alberta states of Canada. According to Health and Safety Executive (HSE), an U.K based organization, each year in the U.K 200 to 300 new cases of occupational asthma, 4,000 COPD deaths, 200 to 300 new cases of Pneumoconiosis, and 20-50 new cases of Silicosis were reported. In 2015, it also reported 2,542 mesothelioma and 467 asbestos related deaths.
Inhalers play a pivotal role in treatment of asthma and chronic obstructive pulmonary disease. The importance of the inhalation is delivery of medicines that directly acts on air passage and lungs. This signifies the higher concentrations of drug at target site, with lower systemic exposure thus also have low adverse effects than the oral or intravenous administration of drug. The drawback of inhalers are that it leads to suboptimal use and low efficacy. The design of inhalers also plays an important role in drug deposition, the characteristics of the inhaled medicine, and on the ability of the patient to use the device.
Key takeaways of the market:
  • The global respiratory inhalers market is expected to expand at a CAGR of 7% during the forecast period (2017–2025) as there exists a huge unrealized market especially in Asia Pacific, Latin America, Middle East and Africa
  • Asthma, a therapeutic application segment is expected to dominate the market throughout the forecast period with increasing prevalence of asthma
  • North America is expected to dominate the market, owing to the increasing usage of smart inhalers during the forecast period
  • Some of the major players involved in global respiratory inhalers market are AstraZeneca, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim GmbH, Cipla Ltd., GlaxoSmithKline plc, Koninklijke Philips N.V., Merck & Co., Inc., OMRON Healthcare Europe B.V., PARI Medical Holding and Teva Pharmaceutical Industries Ltd.
  • The key players are focusing on combinational therapies, which will drive the market forward
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Posted by at No comments:

Global Avocado Oil Market to Surpass US$ 177.4 Million by 2025

The global avocado oil market was valued at  US$ 62.8 million in 2016 and is expected to reach  US$ 177.4 million by 2025, witnessing a CAGR of 12.27% over the forecast period (2017-2025), according to Avocado Oil Market, by Product Type (Virgin Oil, Extra Virgin Oil, Refined Oil, and Blend), by Application (Personal Care Products, Cooking, Medicinal Products, and Others), and by Distribution Channel (Hypermarkets, Supermarkets, Specialty Stores, Convenience Stores, and Others) published by Coherent Market Insights. Avocado oil is extracted from the pulp of avocado fruit originated in Central America and Mexico. High protein, antioxidant, good fats, soluble and insoluble fibers, and various minerals and vitamins are some of the benefits associated with avocado oil, which in turn increases its demand and fueled growth of the avocado oil market. Furthermore, it is also used in the treatment of health related problems as coronary heart diseases, leading to growth of the market. In 2017, avocado oil is listed as a prescription drug in France for the treatment of knee and hip osteoarthritis, owing to its ability to counter the negative effects of arthritis when taken internally. They are considered to be as healthy as almond or olive, however are more expensive, which in turn hampers the market growth.
To know the latest trends and insights prevalent in this market, click the link below: 
Browse 350 pages, 150 market data tables* and 90 figures* on "Avocado Oil Market” - Global forecast to 2025.
Key Trends and Analysis of the Avocado Oil Market:
  • Among product types, the extra virgin oil segment accounted to held highest market share in the avocado oil market, mainly owing to its high smoke point. The extra virgin oil has high nutritional content, strong flavor, and aroma as it is produced at low temperature. It has a natural taste, as coloring agents and artificial flavors are not added. Moreover, it is used in spreading, emulsifying, drizzling, dipping, and other cooking processes.
  • Among applications, personal care product segment accounted for a dominant position in market in 2016 and is expected to maintain its dominance over the forecast period. This is mainly owing to properties of avocado oil such as high absorption and skin penetration. Cosmetic Ingredient Review (CIR) Expert Panel has assessed the safety for use of avocado in cosmetics and personal care products.
Key Takeaways of the Market:
  • According to Coherent Market Insights’ study, North America held a largest market share, in terms of volume, in the global avocado oil market in 2016. North America market is driven by increasing number of chronic and heart diseases. According to the Centers for Disease Control and Prevention (CDC), around 49% of people in U.S. have at least one of the risk factors of heart diseases that include high cholesterol level, high blood pressure, and smoking habits. This led 366,000 deaths in 2015.
  • Asia Pacific holds a second largest position in the global avocado oil market, owing to increasing consumer awareness related to healthy lifestyle and increasing use of cosmetic and personal products. According to India Brand Equity Foundation (IBEF), per capita spend on beauty and personal care products was valued at US$ 7 billion in India. Increasing consumption of avocado in Asia Pacific, especially in economies such as Japan, South Korea, and Malaysia, which imports avocado products from South Africa, Mexico, Peru, Chile, and U.S. According to China Business Network, the overall consumption of avocado in China was estimated to around 4,000 tons in 2014, a significant increase as compared to previous years.
  • Manufacturers are focusing towards expanding their product portfolio. In 2017, Good Health, the manufacturer of snacks, expand its portfolio with an exciting line of Avocado Oil Ridge Cut Potato chips launched at Natural Products West.
  • The key players operating in the global avocado oil market include Sesajal S.A. de C.V., Olivado, Grupo Industrial Batellero S.A. de C.V, YASIN, Tron Hermanos SA de CV, The Village Press, Bella Vado, Chosen Foods LLC, and Storino's Quality Products.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Posted by at No comments:

Increasing Wind Turbine Installation in Onshore and Offshore Areas are Expected to Drive the Anemometer Market Growth

According to the new market research report 'Global Anemometer Market, by Product Type (Velocity Anemometer and Pressure Anemometer), by Technology (LIDAR and SODAR), by Application (Onshore and Offshore), by End-Use Industry (Agriculture, Aviation, Oil & Gas, Marine, Transport & Logistics, Renewables, and Others), and by Geography (North America, Europe, Asia Pacific, Latin America, Africa, and Middle East) - Global Forecast to 2025', is estimated to be valued at over US$ 561.85 million by 2025 and expected to exhibit a CAGR of 5.79% during the forecast period (2017 – 2025), as highlighted in a report published by Coherent Market Insights.

Increasing number of wind energy generation projects, with total 486,790 MW installed wind power capacity in 2016 and the rising demand for modern instruments for air speed, air quality and velocity measurement, due to the rising environmental pollution, is boosting the market growth globally. Increasing number of wind turbine installations is further fueling the market growth. According to the International Renewable Energy Agency (IRENA), the global cumulative renewable generation capacity reached 2,006 GW in 2016 grew by 8.7%, with a record of 71 GW new solar energy, the first time since 2013 that solar energy outpaced wind energy capacity additions. Wind energy accounted for 51 GW of new capacity addition of this.

Browse over 00340 Market Data Tables and 60 Figures spread through over 300 Pages and in-depth TOC on " Global Anemometer Market, by Product Type (Velocity Anemometer and Pressure Anemometer), by Technology (LIDAR and SODAR), by Application (Onshore and Offshore), by End-Use Industry (Agriculture, Aviation, Oil & Gas, Marine, Transport & Logistics, Renewables and Others), and by Geography (North America, Europe, Asia Pacific, Latin America, Africa and Middle East) - Global Forecast to 2025".

To know the latest trends and insights prevalent in the global anemometer market, click the link below

Key Takeaways of the Anemo meter Market:
  • The global Anemometer market is projected to reach over US$ 561.85 million by 2025, exhibiting a CAGR of 5.79% over the forecast period.
  • Among velocity anemometers, the hot wire anemometers accounts for largest market share, as it is widely used for evaluating the velocities of wind across various industries such as chemicals and oil & gas.
  • North America accounted largest market share in anemometer market, in 2016, followed by Europe and Asia Pacific respectively. According to The Global Wind Energy Council (GWEC), total wind power installed capacity in North America was 97,611 MW in 2016.
  • China is the leading market for anemometer in Asia Pacific region. According to GWEC, China has largest share of new installed wind capacity and cumulative capacity with 42.7% and 34.7% respectively in 2016, followed by Japan, South Korea, Taiwan and India, respectively. The total wind power installed capacity in China was 168,732 MW, in 2016.
  • Germany, the U.K., and France contributed significant shares in the anemometer market across Europe, with 10%, 1.3%, and 2.9% wind installed capacity, in 2016, respectively. Germany ranked 3 in the global wind power installed capacity in 2016, according to GWEC.
  • The UAE, South Africa, Brazil and Argentina are dominant markets for anemometer across Middle East and Africa and Latin America. According to GWEC, Brazil ranked fifth in the global wind power installed capacity in 2016 with 2,014 MW of wind power installed and 3.7% of global market share.
  • Key companies covered as a part of this study include Ammonit Measurement, FT Technologies, Gill Instruments, Lufft, Siemens, Delta Ohm Benelux, IED Electronics, LCJ Capteurs, Maretron, NRG Systems, PCE Deutschland and Vaisala.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Posted by at No comments:

Global Waterproof Socks Market to Surpass US$ 7,525.8 Million by 2025

The global waterproof socks market was valued at US$ 3,790.1 million in 2016 and is expected to reach US$ 7,525.8  million by 2025, witnessing a CAGR of  8.0% over the forecast period (2017-2025), according to a Waterproof Socks Market Report, by Gender (Male and Female), by Age Group (Up to 15 years, 15 to 30 years, 30 to 45 years, 45 to 60 years, and above 60 years), and by Distribution Channel (Supermarket, Hypermarket, Specialty Stores, Convenience Stores, and Others). Waterproof socks prevent penetration of water, thereby keeping the feet dry. They can also provide breathability, protection from wind, and thermal protection. They are mainly used during activities such as rafting, rainforest trekking, mountaineering, mountain biking, snow sports, and other outdoor activities. Growing number of people opting for vacations involving outdoor activities and adventure activities such as hiking, mountaineering, and rafting is propelling growth of the waterproof socks market. Low market penetration in developing countries such as Brazil, India, Argentina and China amongst others   is one of the barrier to the waterproof socks market.
To know the latest trends and insights prevalent in this market, click the link below:
Browse 400 pages, 150 market data tables* and 60 figures* on "Waterproof Socks Market” - Global forecast to 2025.
Key Trends and Analysis of the Waterproof Socks Market:
  • Among gender segments, the males segment is the largest segment, as males are more active in outdoor activities as compared to females. For instance, according to Sports England, a public body under the Department for Culture, Media, and Sport, 65% of males are engaged in outdoor activities such as mountaineering in the U.K.
  • Among age groups, the 30-45 age segment was the largest segment, owing to high participation of people aged between 30 and 45 years, in outdoor recreational activities. For instance, according to 2015 Mountain Biking Survey by International Mountain Biking Association (IMBA), 32% of the population aged between 36 and 45 years, 31% between 26 and 35 years, and 18% between 46 and 55 years participated in mountain biking in Europe Union countries.
Key Takeaways of the Market:
  • According to Coherent Market Insights study, Asia Pacific accounted for the largest market share of 32.31% in terms of revenue in the global waterproof socks market in 2016. This is attributed to increasing demand for waterproof socks in snow sports, hiking, and trekking coupled with growing inclination towards these sports in the region. For instance, according to a report published on Special Interest Sector by New Zealand Tourism, in March 2017, 73% of holiday visitors are estimated to be participated in walking and hiking activities over the last three years in the region.
  • Europe is the second-largest waterproof socks market due to the high participation of the populace in outdoor recreational activities such as walking, camping, mountaineering, mountain biking, orienteering, running, and snow sports. For instance, according to Sports England which is public body under the Department for Culture, Media and Sport, 47% people participate in regular outdoor activities in the U.K.
  • Key players operating in the global waterproof socks market include DexShell, Sealskinz, Showers Pass, Rocky, Wigwam Corporation, Camaro GesmbH, Randy Sun, Seavenger, Neo Sport, and NRS.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Posted by at No comments:

Global Vetiver Oil Market to Surpass US$ 172.2 Million by 2025

The global vetiver oil market was valued at US$ 56.3 million in 2016 and is projected to reach US$ 172.2 million by 2025, exhibiting a CAGR of 13.71% during the forecast period, according to Vetiver Oil Market, by Application (Fragrances, Food & Beverages, Pharmaceuticals, and Others) published by Coherent Market Insights.
Growing urbanization in Asia Pacific, especially in emerging economies such as India, China, and ASEAN, coupled with increasing sales of vetiver oil fragrances among the populace has fueled growth of the vetiver oil market.
To know the latest trends and insights prevalent in this market, click the link below:
Browse 100 market data tables* and 60 figures* on "Vetiver Oil Market” - Global forecast to 2025.
Key Trends and Analysis of the Vetiver Oil Market:
  • Among applications, the fragrances segment accounted for the largest market share in 2016. Rising sales of fragrances in Asia Pacific and Latin America has augmented growth of the vetiver oil market. According to the Fragrance & Flavour Development Centre in India, the sales of fragrances in the country topped US$ 450 million in 2014 and is expected to double by 2019. Increased male vanity has contributed to the growth of the fragrances market, which in turn, has fueled the vetiver oil market growth. Vetiver oil has a woody and earthy scent, which is further used as a major constituent in premium male perfumes.
  • Europe and North America are expected to be the lucrative regions for pharmaceutical application segment. Vetiver oil is used in aromatherapy, which further fuels growth of the market in these regions. Growing preference for organic products in Western Europe and North America, has increased demand for vetiver oil in fragrances and food & beverages flavoring. According to the U.S Department of Agriculture, 4% of total food sales in the U.S. in 2016 were organic products.
Key Takeaways of the Market
  • According to Coherent Market Insights’ study, Europe accounted for the largest market share in the global vetiver oil market in 2016. The region is expected to witness steady growth exhibiting a CAGR of 13.34%. This is mainly attributed to increasing popularity of vetiver oil in pharmaceutical applications such as scar treatment, sedative, nervine, and antiseptic. The pharmaceutical application segment is expected to be the fastest growing segment in the forecast period.
  • Increasing use of vetiver oil for treatment of anxiety, depression, stress disorders, and psychiatric illnesses has propelled the market growth. According to Anxiety and Depression Association of America, around 40 million adults suffered from anxiety disorders in the U.S. in 2016. Moreover, according to World Health Organizations (WHO), the prevalence of mental health disorders has increased from around 416 million in 1990 to around 615 million in 2013. These factors are expected to fuel growth of the vetiver oil market.
  • Asia Pacific is projected to be the fastest growing region in the global vetiver oil market, witnessing a CAGR of 16.45% over the forecast period. China and India are the major growth engines of the market in Asia Pacific. This is attributed to rampant growth of pharmaceuticals and fragrances industries in the region. According to Indian Brand Equity Foundation, the pharmaceutical industry in India was valued at US$ 20 billion in 2015.
  • Major players operating in the global vetiver oil market include International Fragrance and Flavor Inc., Lluch Essence SL, UniKode S.A., Frager S.A., Robertet Group, Ernesto Ventos S.A., Floracopeia Inc., Fleurchem Inc., and Haiti Essential Oil Co. S.A.
  • Highly concentrated nature of production sites of vetiver oil, the companies are focusing on investing across the supply chain to achieve cost integration.
  • For instance, International Fragrance and Flavor Inc. initiated “Vetiver Together” partnership with a key customer and several NGOs to strengthen the supply chain. Moreover, the initiative aims to improve the financial condition of Haitian vetiver farmers, who are highly dependent on income from vetiver crop. This is expected to prevent premature harvesting of vetiver roots, which results in the production of degraded quality of vetiver oil. Harvesting of vetiver root at optimum timeframe (12 to 18 months) is expected to lead the production of a higher quality of vetiver oil.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Posted by at No comments:

Generic Oncology Sterile Injectables Market to Surpass US$ 23.40 Billion Threshold by 2025

The global generic oncology sterile injectable market By Product Type (Chemotherapy, Monoclonal Antibodies, Cytokines, and Peptide Hormones), By Disease Indication (Ovarian Cancer, Breast Cancer, Lung Cancer, Pancreatic Cancer, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 8.9 billion in 2016 and is projected to expand at a CAGR of 11.4% over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Rising incidence and prevalence of multiple cancer such as ovarian cancer, breast cancer, lung cancer, and pancreatic cancer and growing need for treatment are expected to be major driving factors for generic oncology sterile injectable market growth over the forecast period.
According to the World Health Organization (WHO), in 2012, around 14 million new cases of cancer were reported. Moreover, according to the WHO, cancer is a second leading cause of mortality, worldwide. Furthermore, according to the Cancer Research UK, in 2012, over 4 in 10 of new cases of cancer are breast, lung, bowel or prostate cancer. Moreover, according to the Cancer Research UK, in 2014, around 356,860 new cases of cancer were estimated in the U.K. Furthermore, according to the Centers for Disease Control and Prevention (CDC), in 2015, approximately 21.1 million adults were diagnosed with cancer in the U.S. Therefore, rising high prevalence of cancer requires proper treatment management for better patient outcome. This is expected to aid in generic oncology sterile injectable market growth over the forecast period.
In May, 2017, India based Dr. Reddy's Laboratories received U.S. Food and Drug Administration (FDA) approval for its Doxorubicin Hydrochloride Liposome Intravenous injection in the U.S. market. The product is a generic version of Doxil, a chemotherapy drug used in stopping cancerous cell growth. It can be used for treatment of multiple myeloma, ovarian cancer, and AIDS-related Kaposi's sarcoma. This U.S. FDA authorization was an outcome of collaboration result of Natco Pharma Limited with Dr. Reddy’s Laboratory. Therefore, development of oncology specific generic sterile injectables and strategic collaborations by manufacturers is expected to support growth of the generic oncology sterile injectables market over the forecast period.
Browse 28 Market Data Tables and 25 Figures spread through 140 Pages and in-depth TOC on generic oncology sterile injectable market by product type (chemotherapy, monoclonal antibodies, cytokines, peptide hormones), by disease indication (ovarian cancer, breast cancer, lung cancer, pancreatic cancer, and others), by distribution channel (hospital pharmacies, retail pharmacies and online pharmacies), and by region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2025
To know the latest trends and insights prevalent in the generic oncology sterile injectable market, click the link below:
Key Takeaways of the Generic Oncology Sterile Injectable Market:
  • The global generic oncology sterile injectables market is expected to expand at a CAGR 11.4% over the forecast period (2017–2025) due to rampant increase in incidence rate of cancer and other chronic conditions
  • Among product types, monoclonal antibodies held the dominant position in the global generic oncology sterile injectables market in 2016. This is attributed to properties of monoclonal antibody to specifically target the cancer cell and these have less side-effects compare to chemotherapy.
  • Among disease indications, other cancers (melanoma, brain cancer, prostate cancer, etc.) is a major disease indication segment in the global generic oncology sterile injectable market, as there have been a spur in product launches for these cancer types in the recent past
Some of the key players in the global generic oncology sterile injectable market are Eli Lilly & Company, Biocon Ltd., Baxter International Inc., Hikma Pharmaceuticals PLC, Mylan N.V., Sandoz International GmbH, Teva Pharmaceutical Industries Ltd., and Pfizer Inc.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Posted by at No comments:

Laparoscopic Devices Market to Surpass US$ 14,777.3 Million by 2025

The global laparoscopic devices system market by Product Type ( Laparoscope, Hand Access Instrument, Energy Products, Trocars/Access Device, Robot Assisted System, Insufflation Devices, Suction/ Irrigation Device, and Closure Devices), by Application (Bariatric Surgery, Colorectal Surgery, Gynecological Surgery, and Urological Surgery) by End User (Hospital, Clinics, and Ambulatory Surgical Centers ) and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 7,635.2 million in 2016 and is projected to exhibit a CAGR of 7.7% over the forecast period (2017–2025), as highlighted in a report published by Coherent Market Insights. Increasing demand for minimal invasive surgeries and advancement in technology in laparoscopic devices is in turn projected to support growth of the laparoscopic devices market over the forecast period.

Continuous upgradation of old surgical instruments intended to be utilized in laparoscopic procedures is the major factor for growth of laparoscopic devices market. For instance, needle holder is used by surgeons to hold suturing needles during laparoscopy. Probe, scalpel, and cannula together form a trocar, and is widely used in laparoscopic surgeries. Bowel grasper enables surgeons to grasp and manipulate abdomen tissue with precision. 

Manufacturers are focusing on innovation and new product launches to enhance its product portfolio and expand its presence. For instance, in August 2017, Ethicon, a part of the Johnson & Johnson Medical Devices Companies, launched the ProxiSure, an advanced laparoscopic suturing device featuring Ethicon endomechanical, suture, and curved needle technologies. Intuitive Surgical, announced in May 2017, that the company’s new da Vinci X Surgical System received US Food and Drug Administration (FDA). In October 2017, the Senhance system, which is a robotically assisted surgical device that can be used in laparoscopic colorectal and gynecologic surgery, manufactured by TransEnterix Surgical, Inc. received the U.S. FDA approval. Manufacturers are strategizing on offering medical robotic systems at lower costs and with several features, which in turn favors growth of laparoscopic devices market.

Browse 30 Market Data Tables and 24 Figures spread through 156 Pages and in-depth TOC on Laparoscopic Devices Market by Product Type (Laparoscope, Hand Access Instrument, Energy Products, Trocars/Access Device, Robot Assisted System, Insufflation Devices, Suction/ Irrigation Device and Closure Devices), by Application (Bariatric Surgery, Colorectal Surgery, Gynecological Surgery, and Urological Surgery) by End User (Hospital, Clinics, and Ambulatory Surgical Centers) and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa)  - Global Forecast to 2025

To know the latest trends and insights prevalent in the global laparoscopic devices market, click the link below:

Manufacturers are also focusing on collaborations and acquisitions to strengthen their product portfolio related to laparoscopic devices. For instance, Globus Medical acquired KB Medical, a robotic company-based in Switzerland, in August 2017. This acquisition aided in bolstering the product portfolio and intellectual property of the Globus Medical. Stryker Corp. In September 2013, the company also acquired Mako Surgical Corp and its robotic surgery platform for around US$ 1.65 Bn, which helped Stryker to use its own implants with Mako’s surgical systems. Zimmer Biomet entered the surgical robotic market through the acquisition of a France-based company Medtech SA, by purchasing around 59% of the outstanding share capital of Medtech in July 2016. Medtech SA is a developer and manufacturer of the ROSA robotic device used for neurological and spine procedures, which had received FDA approval in January 2016.
Furthermore, Verily Life Sciences LLC in collaboration with Johnson & Johnson, formed Verb Surgical Inc., in March 2015. Verb Surgical focuses on developing a comprehensive surgical solutions platform to improve access to minimal invasive surgery. These are expected to favor growth of the laparoscopic devices market.
However, high costs associated with laparoscopic devices and lack of trained-healthcare professionals is expected to act as a restraint for growth of the laparoscopic devices market.


Key takeaways of the market:
  • The global laparoscopic devices market is expected to exhibit a CAGR of 7% over the forecast period (2017–2025), owing to increasing demand for minimal invasive procedure. Asia Pacific region in the global laparoscopic devices market is expected to exhibit high growth rate, in terms of value, over the forecast period.
  • Among product types, energy products segment is expected to exhibit a significant CAGR of 5%.
Some major players operating in the global laparoscopic devices market are Stryker Corporation, Johnson & Johnson, Karl Storz GmbH & Co.KG, Boston Scientific Corporation, Medtronic PLC. (Covidien), Olympus Corporation, Richard Wolf GmbH, ConMed Corporation, B. Braun Melsungen AG, and Smith & Nephew PLC.

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Posted by at No comments:

Global Nutraceutical Ingredients Market to Surpass US$ 57.46 Billion by 2025

Global nutraceutical ingredients market was valued at US$ 30.57 billion in 2016, according to Global Nutraceutical Ingredients Market by Product Ingredients (Vitamins, Prebiotics, Proteins and Amino Acids, Omega Fatty 3 Acids, and Others), by Application (Functional Food, Functional Beverages, Dietary Supplements, and Others), by Form (Dry and Liquid) published by Coherent Market Insights. The nutraceutical ingredients market is expected to exhibit a CAGR of 7.31% over the forecast period (2017–2025) to reach US$ 57.46 billion by 2025.
Key drivers for growth of the nutraceutical ingredients market is the associated health benefits of its consumption such as delay in aging process, supports functions of the body, provides prevention from chronic diseases and increases life expectancy. Furthermore, consumption of nutraceutical ingredients is expected to aid in maintaining health of an individual and reducing the risk of chronic diseases such as cancer, diabetes, obesity, and various others. Another factor expected to drive growth of the market is increasing micronutrient deficiency among individuals. According to Food and Agriculture Organization (FAO), United Nations, one in three people suffer from micronutrient deficiency, globally.
However, demand of these ingredients increases owing to limited manufacturing of nutraceuticals, and delay in the lab to market supply chain are one of the major factors restricting the growth of global nutraceutical ingredients market.
To know the latest trends and insights prevalent in this market, click the link below:
Browse 100 market data tables* and 60 figures* on "Nutraceutical Ingredients Market”- Global forecast to 2025.
Key Trends and Analysis of Nutraceutical Ingredients Market:
  • Among product ingredients, omega fatty 3 acids segment is expected to exhibit fastest growth in the nutraceutical ingredients market with a CAGR of 7.33% over the forecast period. This high growth is owing to the benefits of Omega fatty 3 acid in reducing controlling cholesterol and blood pressure.
  • Among form, dry was the dominant segment in 2016 and is expected to continue its dominance over the forecast period. This growth is due to the factor that formulating dry ingredients is easier, especially to manufacture high volume.
  • Among application, functional beverages was the dominant segment in 2016 with a market share of 34.37% and is expected to retain its dominance over the forecast period. According to (Federation of Indian Chambers of Commerce & Industry (FICCI), in 2010 the global consumption of functional beverage was around 36%, which was the highest product segment. In 2011, Assure Food & Beverage Company, launched two new healthy beverages, Tropical Tangerine — helps to recover fatigue and maintains healthy heartbeat after intense exercise and Kiwi Strawberry Melon — contains omega 3 fatty acid which aids in reducing risk of coronary heart disease.
Key Takeaways of the Market:
  • Asia Pacific was the dominant region in the nutraceutical ingredients market in 2016 with a share of 36.19% and is expected to retain its dominance over the forecast period. In the recent past, Singapore has become a center for R&D. Companies such as Wacker, DuPont, and Tate & Lyle have augmented their activities in Singapore. BASF introduced a technical application laboratory in this country, for its health and nutrition business, to further drive R&D capacities.
  • North America accounted for a significant share in the global nutraceutical ingredients market in 2016. The U.S. is the major country in nutraceutical ingredients market in North America. According to U.S. department of Health and Human Services, around 59 million Americans spend US$ 30.2 billion annually on healthcare.
Major players operating in the global nutraceutical ingredients market include BASF SE, E.I. du Pont de Nemours and Company, Cargill Inc., Archer Daniels Midland Company, DSM Nutritional Products, Ingredion Incorporated, Tate & Lyle Plc, Ajinomoto Co. Inc., and FMC Corporation.

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Posted by at No comments:
Subscribe to: Posts (Atom)